RE:RE:RE:3yr wait for at best coin flip odds & binary outcome...@Short
It is clear you like to throw out specualtive thoughts with zero DD and data to support them. You offer zero reason to read any of your further posts. Your agenda is telling..
1 - NSAID market is roughly $10B+ (Antive claims $16B). Taking even 3% -5% is a considerable prize. How can antibe do this...
2 - Otenaproxesul greatly reduces ulcers.. "Each year, the side effects of long-term NSAID use cause nearly 103,000 hospitalizations and 16,500 deaths. More people die each year from NSAIDs-related complications than from AIDS and cervical cancer in the United States."
Clearly a need for a better drug is there..Link below
3 - I suggest you study the history and sales of Celebrex, Vioxx (both NSAID) to understand the money makers these drugs were before their set backs.. Both had sales in excess of $1.5B in their first year on the market. BP likes blockbusters in the pain space. Period.
https://www.sciencedaily.com/releases/2005/01/050111123706.htm
https://antibethera.com/wp-content/uploads/2020/08/Antibe-Corporate-Presentation-August-2020.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310346/